thejoe Attix Pharmaceuticals

Attix Pharmaceuticals: 470 FDA recall reports

Every drug recall the FDA has published for Attix Pharmaceuticals. The fault, and how the agency graded it.

470Reports

0Class I

0Ongoing

2015-04-29Most recent

What the classes mean

The FDA sorts every recall into one of three classes. The class is the whole story. It is also the part people skip.

Class	What the FDA is saying
Class I	There is a reasonable probability that using this will cause serious harm or death.
Class II	It may cause temporary or reversible harm. Serious harm is unlikely.
Class III	It breaks a rule but is unlikely to hurt anyone. Often a labelling fault.

Class II is the bulk of every list here. That matters. A long list of Class II says something different from one Class I.

By class

Class	Reports
Class II	470

Checking whether it affects you

The lot or code number is what matters. Not the product name. A recall covers specific lots. Yours may not be one of them.

Check the code on your package against the report. The FDA keeps the current list at fda.gov/safety/recalls.

The reports

The text below is quoted from the FDA record word for word.

Homatropine Methylbromide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, A

D-707-2015 · Class II · reported 2015-04-29 · Terminated

Why it was recalled: Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
Product: Homatropine Methylbromide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Where it went: Nationwide to compounding pharmacies and research organizations.
How much: 940 grams

Methyl Folate Calcium active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix

D-790-2015 · Class II · reported 2015-04-29 · Terminated

Why it was recalled: Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
Product: Methyl Folate Calcium active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Where it went: Nationwide to compounding pharmacies and research organizations.
How much: 5 grams

Diphenylcyclopropenone active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Atti

D-633-2015 · Class II · reported 2015-04-29 · Terminated

Why it was recalled: Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
Product: Diphenylcyclopropenone active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Where it went: Nationwide to compounding pharmacies and research organizations.
How much: 100 grams

Tolvaptan active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuti

D-935-2015 · Class II · reported 2015-04-29 · Terminated

Why it was recalled: Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
Product: Tolvaptan active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Where it went: Nationwide to compounding pharmacies and research organizations.
How much: 50 grams

Lidocaine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmac

D-762-2015 · Class II · reported 2015-04-29 · Terminated

Why it was recalled: Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
Product: Lidocaine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Where it went: Nationwide to compounding pharmacies and research organizations.
How much: 33300 grams

4-Aminopyridine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharm

D-492-2015 · Class II · reported 2015-04-29 · Terminated

Why it was recalled: Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
Product: 4-Aminopyridine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Where it went: Nationwide to compounding pharmacies and research organizations.
How much: 1310 grams

Vidarbine Monophosphate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Att

D-953-2015 · Class II · reported 2015-04-29 · Terminated

Why it was recalled: Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
Product: Vidarbine Monophosphate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Where it went: Nationwide to compounding pharmacies and research organizations.
How much: 50 grams

Ethinyl Estradiol active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pha

D-661-2015 · Class II · reported 2015-04-29 · Terminated

Why it was recalled: Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
Product: Ethinyl Estradiol active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Where it went: Nationwide to compounding pharmacies and research organizations.
How much: 146 grams

Uridine-5'Triphosphate Trisodium Salt active pharmaceutical ingredient packaged in varying grams or kg in bags

D-946-2015 · Class II · reported 2015-04-29 · Terminated

Why it was recalled: Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
Product: Uridine-5'Triphosphate Trisodium Salt active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Where it went: Nationwide to compounding pharmacies and research organizations.
How much: 2000 grams

Roflumilast active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceu

D-884-2015 · Class II · reported 2015-04-29 · Terminated

Why it was recalled: Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
Product: Roflumilast active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Where it went: Nationwide to compounding pharmacies and research organizations.
How much: 10 grams

Belladonna Extract Powder active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, A

D-535-2015 · Class II · reported 2015-04-29 · Terminated

Why it was recalled: Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
Product: Belladonna Extract Powder active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Where it went: Nationwide to compounding pharmacies and research organizations.
How much: 7800 grams

Ibuprofen active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuti

D-727-2015 · Class II · reported 2015-04-29 · Terminated

Why it was recalled: Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
Product: Ibuprofen active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Where it went: Nationwide to compounding pharmacies and research organizations.
How much: 4000 grams

Bovine Insulin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharma

D-546-2015 · Class II · reported 2015-04-29 · Terminated

Why it was recalled: Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
Product: Bovine Insulin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Where it went: Nationwide to compounding pharmacies and research organizations.
How much: 10 grams

Methotrexate Sodium active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix P

D-785-2015 · Class II · reported 2015-04-29 · Terminated

Why it was recalled: Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
Product: Methotrexate Sodium active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Where it went: Nationwide to compounding pharmacies and research organizations.
How much: 25 grams

2-Deoxy-D-Glucose active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pha

D-493-2015 · Class II · reported 2015-04-29 · Terminated

Why it was recalled: Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
Product: 2-Deoxy-D-Glucose active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, On
Where it went: Nationwide to compounding pharmacies and research organizations.
How much: 3100 grams

Lodenafil Carbonate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix P

D-767-2015 · Class II · reported 2015-04-29 · Terminated

Why it was recalled: Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
Product: Lodenafil Carbonate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Where it went: Nationwide to compounding pharmacies and research organizations.
How much: 100 grams

Levothyroxine Sodium (T4) active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, A

D-761-2015 · Class II · reported 2015-04-29 · Terminated

Why it was recalled: Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
Product: Levothyroxine Sodium (T4) active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Where it went: Nationwide to compounding pharmacies and research organizations.
How much: 4605 grams

Melphalan active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuti

D-777-2015 · Class II · reported 2015-04-29 · Terminated

Why it was recalled: Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
Product: Melphalan active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Where it went: Nationwide to compounding pharmacies and research organizations.
How much: 132 grams

Pioglitazone HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Phar

D-843-2015 · Class II · reported 2015-04-29 · Terminated

Why it was recalled: Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
Product: Pioglitazone HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Where it went: Nationwide to compounding pharmacies and research organizations.
How much: 1000 grams

Mebendazole active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceu

D-772-2015 · Class II · reported 2015-04-29 · Terminated

Why it was recalled: Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
Product: Mebendazole active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Where it went: Nationwide to compounding pharmacies and research organizations.
How much: 7000 grams

Pancuronium Bromide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix P

D-830-2015 · Class II · reported 2015-04-29 · Terminated

Why it was recalled: Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
Product: Pancuronium Bromide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Where it went: Nationwide to compounding pharmacies and research organizations.
How much: 20 grams

Paromomycin Sulphate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix

D-832-2015 · Class II · reported 2015-04-29 · Terminated

Why it was recalled: Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
Product: Paromomycin Sulphate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Where it went: Nationwide to compounding pharmacies and research organizations.
How much: 25 grams

Gabapentin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceut

D-696-2015 · Class II · reported 2015-04-29 · Terminated

Why it was recalled: Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
Product: Gabapentin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Where it went: Nationwide to compounding pharmacies and research organizations.
How much: 365402 grams

Magnesium Stearate pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceu

D-771-2015 · Class II · reported 2015-04-29 · Terminated

Why it was recalled: Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
Product: Magnesium Stearate pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Where it went: Nationwide to compounding pharmacies and research organizations.
How much: 3000 grams

Mitotane active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceutic

D-804-2015 · Class II · reported 2015-04-29 · Terminated

Why it was recalled: Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
Product: Mitotane active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Where it went: Nationwide to compounding pharmacies and research organizations.
How much: 21500 grams

Nevirapine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceut

D-816-2015 · Class II · reported 2015-04-29 · Terminated

Why it was recalled: Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
Product: Nevirapine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Where it went: Nationwide to compounding pharmacies and research organizations.
How much: 100 grams

Acetazolamide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmac

D-499-2015 · Class II · reported 2015-04-29 · Terminated

Why it was recalled: Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
Product: Acetazolamide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Where it went: Nationwide to compounding pharmacies and research organizations.
How much: 2100 grams

Baclofen active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceutic

D-534-2015 · Class II · reported 2015-04-29 · Terminated

Why it was recalled: Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
Product: Baclofen active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Where it went: Nationwide to compounding pharmacies and research organizations.
How much: 134535 grams

Nitazoxanide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmace

D-818-2015 · Class II · reported 2015-04-29 · Terminated

Why it was recalled: Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
Product: Nitazoxanide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Where it went: Nationwide to compounding pharmacies and research organizations.
How much: 9550 grams

Amikacin Sulfate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Phar

D-511-2015 · Class II · reported 2015-04-29 · Terminated

Why it was recalled: Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
Product: Amikacin Sulfate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Where it went: Nationwide to compounding pharmacies and research organizations.
How much: 7500 grams

Showing the 30 most recent of 470. The rest are searchable at the FDA enforcement report database.

Read these counts with three things in mind

A firm with more recalls usually makes more products. A contract packer runs hundreds of lines. It will out-recall a company with one product whatever either does. This is not a safety ranking.

Most recalls here are voluntary. A firm found its own fault and pulled the stock. That is the system working. It lands in this database looking the same as a recall the FDA had to push for.

Terminated means the FDA considers the recall finished. It is not a verdict. It does not mean anyone was harmed.

Source: openFDA enforcement reports, retrieved 2026-08-05. FDA dataset last updated 2026-07-29.

← All drug recalls